Implications of BRCA Testing in a 27-Year-Old Breast-Feeding Mother With a Strong Family History of Malignancy

Teri Payne


Confidence in identifying and ease of testing for BRCA1 and BRCA2 gene mutations has led to general clinicians ordering BRCA1 and BRCA2 mutations testing more frequently than other cancer genetic tests. When present, these mutations increase breast and ovarian cancer risk dramatically as well as several other cancers. In years past, identification of mutations was saved for an older high-risk patient population; data supporting current management recommendations studied a population mirroring that group. Now, an increasingly younger patient population is having the mutation identified and facing increasingly complicated decisions regarding lifetime risk. Presented here is a case of a 27-year-old breast-feeding mother of two with a strong breast cancer family history, who was found to have an enlarged lymph node and newly identified with a BRCA1 gene mutation. Current recommendation for screening and breastfeeding are presented as well as psychological implication on this increasingly young BRCA1 and BRCA2 gene mutation positive population.

J Med Cases. 2013;4(6):372-375


BRCA1; BRCA2; Breast-feeding; Breast cancer; Ovarian cancer; Implication; Genetic testing; Malignancy

Full Text: HTML PDF

Browse  Journals  


Journal of Clinical Medicine Research

Journal of Endocrinology and Metabolism

Journal of Clinical Gynecology and Obstetrics


World Journal of Oncology

Gastroenterology Research

Journal of Hematology


Journal of Medical Cases

Journal of Current Surgery

Clinical Infection and Immunity


Cardiology Research

World Journal of Nephrology and Urology

Cellular and Molecular Medicine Research


Journal of Neurology Research

International Journal of Clinical Pediatrics



Journal of Medical Cases, monthly, ISSN 1923-4155 (print), 1923-4163 (online), published by Elmer Press Inc.                     
The content of this site is intended for health care professionals.
This is an open-access journal distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License, which permits unrestricted
non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
Creative Commons Attribution license (Attribution-NonCommercial 4.0 International CC-BY-NC 4.0)

This journal follows the International Committee of Medical Journal Editors (ICMJE) recommendations for manuscripts submitted to biomedical journals,
the Committee on Publication Ethics (COPE) guidelines, and the Principles of Transparency and Best Practice in Scholarly Publishing.

website:   editorial contact:
Address: 9225 Leslie Street, Suite 201, Richmond Hill, Ontario, L4B 3H6, Canada

© Elmer Press Inc. All Rights Reserved.

Disclaimer: The views and opinions expressed in the published articles are those of the authors and do not necessarily reflect the views or opinions of the editors and Elmer Press Inc. This website is provided for medical research and informational purposes only and does not constitute any medical advice or professional services. The information provided in this journal should not be used for diagnosis and treatment, those seeking medical advice should always consult with a licensed physician.